Oxbridge Re Holdings Limited (OXBR)
USD 3.66
(-0.54%)
USD 3.66
(-0.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.26 Million | -829 Thousand | -253 Thousand | -266 Thousand | -4.37 Million | -6.63 Million |
| Net Income | -9.91 Million | -1.78 Million | 8.56 Million | -50 Thousand | -305 Thousand | -5.74 Million |
| Depreciation & Amortization | 6000.00 | 4000.00 | 7000.00 | 10 Thousand | 10 Thousand | 18 Thousand |
| Deferred income taxes | -70 Thousand | - | - | - | - | 288 Thousand |
| Stock-based compensation | 258 Thousand | 127 Thousand | 61 Thousand | 32 Thousand | 36 Thousand | 126 Thousand |
| Change in working capital | -216 Thousand | 483 Thousand | 275 Thousand | -39 Thousand | -4.08 Million | 684 Thousand |
| Other non-cash items | 8.67 Million | 346 Thousand | -9.16 Million | -219 Thousand | -28 Thousand | -2 Million |
| Investing Cash Flow | -105 Thousand | -661 Thousand | -1.8 Million | 110 Thousand | 488 Thousand | 5.04 Million |
| Investments in PPE | -5000.00 | - | -3000.00 | -14 Thousand | -1000.00 | - |
| Acquisitions | - | 626 Thousand | 1.8 Million | -124 Thousand | -489 Thousand | - |
| Investment purchases | - | -1.28 Million | -3.14 Million | -2.59 Million | -505 Thousand | -10.91 Million |
| Sales/Maturities of investments | - | 626 Thousand | 1.34 Million | 2.71 Million | 994 Thousand | 15.95 Million |
| Other Investing Activities | -100 Thousand | -626 Thousand | -1.8 Million | 124 Thousand | 489 Thousand | 5.04 Million |
| Financing Cash Flow | 1.18 Million | - | -1000.00 | -384 Thousand | 600 Thousand | 2 Million |
| Debt repayment | -98 Thousand | - | - | -600 Thousand | -600 Thousand | -2 Million |
| Dividends payments | - | - | -1000.00 | -4000.00 | -4000.00 | -35 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.28 Million | - | - | - | - | - |
| Other Financing Activities | 1.28 Million | - | 1000.00 | 220 Thousand | 1.2 Million | 2.03 Million |
| Accounts receivables | -695 Thousand | 2000.00 | 180 Thousand | 42 Thousand | -506 Thousand | 3.79 Million |
| Accounts payables | 62 Thousand | -43 Thousand | 128 Thousand | -70 Thousand | 140 Thousand | 33 Thousand |
| Inventory | 487 Thousand | - | - | - | - | - |
| Other working capital | -70 Thousand | 524 Thousand | -33 Thousand | -11 Thousand | -3.71 Million | -3.14 Million |
| Cash at beginning of period | 3.92 Million | 5.41 Million | 7.47 Million | 8.01 Million | 11.29 Million | 10.88 Million |
| Cash at end of period | 3.74 Million | 3.92 Million | 5.41 Million | 7.47 Million | 8.01 Million | 11.29 Million |
| Capital Expenditure | -5000.00 | - | -3000.00 | -14 Thousand | -1000.00 | - |
| Effect of forex changes on cash | -501 Thousand | - | 1000.00 | - | - | - |
| Net cash flow / Change in cash | -183 Thousand | -1.49 Million | -2.05 Million | -540 Thousand | -3.28 Million | 412 Thousand |
| Free Cash Flow | -1.26 Million | -829 Thousand | -256 Thousand | -280 Thousand | -4.37 Million | -6.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -821 Thousand | -905 Thousand | -2.67 Million | -9.91 Million | -7.3 Million | -85 Thousand |
| Depreciation & Amortization | - | 2000.00 | 6000.00 | 6000.00 | 2000.00 | 1000.00 |
| Deferred income taxes | - | - | -68 Thousand | -70 Thousand | - | - |
| Stock-based compensation | 34 Thousand | 72 Thousand | 56 Thousand | 258 Thousand | 93 Thousand | 55 Thousand |
| Change in working capital | -1.66 Million | 214 Thousand | 222 Thousand | -216 Thousand | 459 Thousand | -1.01 Million |
| Other non-cash items | 618 Thousand | 812 Thousand | 2.55 Million | 8.67 Million | 7 Million | -429 Thousand |
| Investing Cash Flow | - | 448 Thousand | -2.96 Million | -105 Thousand | -100 Thousand | - |
| Investments in PPE | - | - | - | -5000.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 307 Thousand | - | - | - | - |
| Other Investing Activities | - | 141 Thousand | -2.96 Million | -100 Thousand | -100 Thousand | - |
| Financing Cash Flow | 1.54 Million | - | -1.18 Million | 1.18 Million | 2000.00 | 1.34 Million |
| Debt repayment | -1.46 Million | - | -98 Thousand | -98 Thousand | - | -54 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.54 Million | - | -1.28 Million | 1.28 Million | - | 1.28 Million |
| Other Financing Activities | 1.54 Million | - | 196 Thousand | 1.28 Million | 2000.00 | 1.39 Million |
| Accounts receivables | -1.62 Million | 488 Thousand | 488 Thousand | -695 Thousand | 489 Thousand | -1.81 Million |
| Accounts payables | 160 Thousand | -142 Thousand | 14 Thousand | 62 Thousand | 39 Thousand | -30 Thousand |
| Inventory | - | - | - | 487 Thousand | - | - |
| Other working capital | -2.01 Million | 417 Thousand | -280 Thousand | -70 Thousand | -69 Thousand | 824 Thousand |
| Cash at beginning of period | 4.31 Million | 3.74 Million | 3.64 Million | 3.92 Million | 3.48 Million | 3.62 Million |
| Cash at end of period | 3.98 Million | 4.31 Million | 3.74 Million | 3.74 Million | 3.64 Million | 3.48 Million |
| Capital Expenditure | - | - | - | -5000.00 | - | - |
| Effect of forex changes on cash | - | - | - | -501 Thousand | - | - |
| Net cash flow / Change in cash | -327 Thousand | 567 Thousand | 96 Thousand | -183 Thousand | 160 Thousand | -131 Thousand |
| Free Cash Flow | -1.87 Million | 119 Thousand | 96 Thousand | -1.26 Million | 258 Thousand | -1.47 Million |
SUPREMEIND
VPLM
JUBLPHARMA
RIIL
INSE
LIO